Development Level

Tbio 1 | 10,625
Tclin 1 | 602

IMPC Term

preweaning lethality, complete... 1 | 633

Disease

Cancer 2 | 2,346
IGA Glomerulonephritis 2 | 454
Neuropathy 2 | 210
ANGIOTENSIN I-CONVERTING ENZYME, BENIGN SERUM INCREASE 1 | 1
Adenocarcinoma 1 | 115
Albuminuria 1 | 20
Allanson Pantzar McLeod syndrome 1 | 4
Alport syndrome 1 | 21
Anemia 1 | 252
Angioedema 1 | 36
Aortic aneurysm 1 | 34
Asymptomatic left ventricular systolic dysfunction 1 | 1
Atherosclerosis 1 | 275
Axonal neuropathy 1 | 17
Berylliosis 1 | 16
C1 inhibitor deficiency 1 | 9
Cardiac Arrhythmia 1 | 20
Cerebral Hemorrhage 1 | 27
Cerebrovascular accident 1 | 44
Cerebrovascular disease 1 | 231
Charcot-Marie-Tooth disease 1 | 74
Chronic heart failure 1 | 46
Congestive heart failure 1 | 30
Conn's syndrome 1 | 22
Connective tissue disease 1 | 59
Coronary Restenosis 1 | 8
Coronary artery disease 1 | 240
Coronary heart disease 1 | 59
Coughing 1 | 2
Dementia 1 | 129
Dental fluorosis 1 | 16
Diabetes Mellitus, Experimental 1 | 106
Diabetic Nephropathy 1 | 37
Diabetic Retinopathy 1 | 53
Diabetic renal disease 1 | 4
Drug allergy 1 | 36
Exanthem 1 | 39
Extraskeletal Myxoid Chondrosarcoma 1 | 6
Gaucher Disease 1 | 4
Gaucher's disease 1 | 24
Glycogen Storage Disease Type V 1 | 2
Heart disease 1 | 279
Heart failure 1 | 80
Hyperaldosteronism 1 | 27
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Hypertension 1 | 287
Hypertensive disease 1 | 193
Hypertensive disorder 1 | 58
Hypertensive encephalopathy 1 | 3
Hypokalemia 1 | 40
Hypotension 1 | 53
IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO 1 | 2
Impotence 1 | 45
Infant, Premature, Diseases 1 | 1
Intermittent claudication 1 | 16
Kidney Diseases 1 | 86
Kidney Failure, Chronic 1 | 45
Kidney disease 1 | 396
Left Ventricular Hypertrophy 1 | 24
Left ventricular cardiac dysfunction 1 | 9
Lipid metabolism disorder 1 | 102
Liver carcinoma 1 | 217
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lung disease 1 | 132
Lung diseases 1 | 48
Lymphatic system disease 1 | 14
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1(finding) 1 | 2
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 (finding) 1 | 1
Meningococcal Infections 1 | 4
Metabolic syndrome X 1 | 155
Myocardial Infarction 1 | 126
Myocardial Infarction Prevention 1 | 7
Neoplasm Metastasis 1 | 138
Neurodegenerative disease 1 | 383
Non-alcoholic Fatty Liver Disease 1 | 40
Oligohydramnios 1 | 18
Papillary thyroid carcinoma 1 | 37
Peripheral artery disease 1 | 8
Peripheral vascular disease 1 | 90
Pneumonia, Viral 1 | 1
Polycystic kidney disease 1 | 54
Psychoses, Substance-Induced 1 | 17
Pulmonary hypertension 1 | 52
Renal Insufficiency 1 | 10
Renal artery disease 1 | 3
Respiratory Tract Diseases 1 | 6
Severe acute respiratory syndrome 1 | 26
Staphylococcal Infections 1 | 4
Stomach Neoplasms 1 | 282
Sudden death 1 | 2
Superficial Ocular Infection 1 | 6
Transient cerebral ischemia 1 | 14
Uveitis 1 | 103
Vasculitis 1 | 64
facioscapulohumeral dystrophy 1 | 286
hereditary spastic paraplegia 1 | 313
pre-eclampsia 1 | 67
sarcoidosis 1 | 358

Tissue

Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Endocrine System 2 | 18,512
Female tissues 2 | 18,647
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Nervous System 2 | 18,561
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444

Target Family

Enzyme 1 | 4,146
Non-IDG 1 | 11,971

Grant Application

5R00HL088000-06 2 | 2
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Angiotensin-converting enzyme ACE Tclin Enzyme -4.50155 29360.4 544
Protein TFG TFG Tbio Non-IDG -2.21283 157.3 175